Back

Choose your region

Summary
patients treated

Has anyone ever benefited from stem cell?

For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.

FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.

List of patients

List of patients
No. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
4601 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2018 Standard Therapy Germany 19
4602 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2018 Standard Therapy Germany 68
4603 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2018 Standard Therapy Germany 62
4604 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2018 Standard Therapy Germany 67
4605 Apheresis Allogeneic Acute Myeloid Leukemia; Myeloproliferative Syndrome Hematology 2018 Standard Therapy Germany 62
4606 Apheresis Autologous Amyloidosis Hematology 2018 Standard Therapy Germany 72
4607 Apheresis Autologous Amyloidosis Hematology 2018 Standard Therapy Germany 75
4608 Apheresis Allogeneic Aplastic Anemia Hematology 2018 Standard Therapy Germany 61
4609 Apheresis Autologous Apoplexy Hematology 2018 Standard Therapy Germany 3
4610 Apheresis Allogeneic Atypical Chronic Myeloid Leukemia  Hematology 2018 Standard Therapy Poland 58
4611 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2018 Standard Therapy Poland 41
4612 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2018 Standard Therapy Poland 50
4613 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2018 Standard Therapy Poland 34
4614 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2018 Standard Therapy Poland 34
4615 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2018 Standard Therapy Poland 52
4616 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2018 Standard Therapy Poland 46
4617 Apheresis Allogeneic B-Cell Chronic Lymphoblastic Leukemia Hematology 2018 Standard Therapy Poland 65
4618 Apheresis Autologous B-Cell Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Germany 69
4619 Apheresis Autologous B-Cell Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Germany 43
4620 Apheresis Allogeneic B-Cell Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Germany 66
4621 Apheresis Allogeneic B-Cell Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Germany 32
4622 Apheresis Allogeneic Blastic Nk Cell Lymphoma Hematology 2018 Standard Therapy Poland 65
4623 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2018 Standard Therapy Poland 15
4624 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2018 Standard Therapy Poland 2
4625 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2018 Standard Therapy Poland 49
4626 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2018 Standard Therapy Poland 38
4627 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2018 Standard Therapy Poland 63
4628 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2018 Standard Therapy Poland 48
4629 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2018 Standard Therapy Poland 25
4630 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2018 Standard Therapy Poland 41
4631 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2018 Standard Therapy Germany 44
4632 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2018 Standard Therapy Germany 54
4633 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 39
4634 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 63
4635 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 56
4636 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 71
4637 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 51
4638 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 67
4639 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 67
4640 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 49
4641 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2018 Standard Therapy Poland 60
4642 Apheresis Allogeneic Diffuse Large B-Cell Lymphoma Hematology 2018 Standard Therapy Poland 54
4643 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2018 Standard Therapy Germany 71
4644 Apheresis Autologous Diffuse Large B-Cell Lymphoma – Relapse Hematology 2018 Standard Therapy Germany 71
4645 Apheresis Allogeneic Fanconi Anemia Hematology 2018 Standard Therapy Poland 9
4646 Apheresis Allogeneic Follicular Lymphoma Hematology 2018 Standard Therapy Poland 44
4647 Apheresis Autologous Follicular Lymphoma Hematology 2018 Standard Therapy Germany 65
4648 Apheresis Allogeneic Follicular Lymphoma (Non-Hodgkin Lymphoma) Hematology 2018 Standard Therapy Poland 56
4649 Apheresis Autologous Germ Cell Tumor Hematology 2018 Standard Therapy Germany 23
4650 Apheresis Autologous Germ Cell Tumor Hematology 2018 Standard Therapy Germany 31
4651 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 38
4652 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 27
4653 Apheresis Allogeneic Hypoplastic Mds-Eb2 With Incipient Saml Hematology 2018 Standard Therapy Poland 63
4654 Apheresis Autologous Large B-Cell Non-Hodgkin-Lymphoma Hematology 2018 Standard Therapy Germany 66
4655 Apheresis Allogeneic Leukemia Hematology 2018 Standard Therapy Poland 34
4656 Apheresis Allogeneic Lymphomatoid Granulomatosis Hematology 2018 Standard Therapy Germany 36
4657 Apheresis Autologous Mantle Cell Lymphoma Hematology 2018 Standard Therapy Germany 66
4658 Apheresis Autologous Mantle Cell Lymphoma Hematology 2018 Standard Therapy Germany 64
4659 Apheresis Autologous Mantle Cell Lymphoma Hematology 2018 Standard Therapy Germany 44
4660 Apheresis Autologous Mantle Cell Lymphoma Hematology 2018 Standard Therapy Germany 66
4661 Apheresis Autologous Morbus Hodgkin Hematology 2018 Standard Therapy Germany 65
4662 Apheresis Autologous Morbus Hodgkin Hematology 2018 Standard Therapy Germany 31
4663 Apheresis Allogeneic Morbus Hodgkin-Relapse Hematology 2018 Standard Therapy Germany 35
4664 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 67
4665 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 61
4666 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 61
4667 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 66
4668 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 57
4669 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 53
4670 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 57
4671 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 65
4672 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 47
4673 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 60
4674 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 66
4675 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 62
4676 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 67
4677 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 65
4678 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 54
4679 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 58
4680 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 51
4681 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 69
4682 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 52
4683 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 62
4684 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 62
4685 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 65
4686 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 62
4687 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 64
4688 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 63
4689 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 55
4690 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 60
4691 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 61
4692 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 62
4693 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 64
4694 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 55
4695 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 65
4696 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 64
4697 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 52
4698 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 61
4699 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 69
4700 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 73